Patient Satisfaction With Nonopioid Pain Management Following Arthroscopic Partial Meniscectomy and/or Chondroplasty.

Patient Satisfaction With Nonopioid Pain Management Following Arthroscopic Partial Meniscectomy and/or Chondroplasty.

Publication date: May 06, 2019

To evaluate the efficacy of nonopioid pain medication related to patient satisfaction with postoperative pain and identify potential risk factors for decreased patient satisfaction with nonopioid pain medications.

This was a prospective study conducted between January 2017 and April 2018 at a single institution. A power analysis was performed a priori, which determined an appropriate cohort size of 163 patients. Inclusion criteria were all patients older than age 18 who were undergoing a knee arthroscopy for a partial meniscectomy and/or chondroplasty. Patients were prescribed maximum-strength ibuprofen or acetaminophen and completed a preoperative and 2-week postoperative questionnaire to assess satisfaction with pain management.

Among the 163 patients enrolled in the study, the average age was 48.7 years (range 21-73 years); 74 (45%) were male and 89 (55%) were female. Overall, 81.6% (95% confidence interval 75.7% to 87.5%, P

Based on the findings of this study, 82% of patients who undergo arthroscopic partial meniscectomy and/or chondroplasty can achieve satisfactory pain control with nonopioid pain management.

Prospective comparative study: Level II.

Daniels, S.D., Garvey, K.D., Collins, J.E., and Matzkin, E.G. Patient Satisfaction With Nonopioid Pain Management Following Arthroscopic Partial Meniscectomy and/or Chondroplasty. 03499. 2019 Arthroscopy.

Concepts Keywords
Acetaminophen Paracetamol
Arthroscopic Analgesic
Arthroscopy Pain management
Cohort Arthroscopy
Confidence Interval Palliative care
Ibuprofen Opioids
Opioid Nociception
Opioids Acute pain
Pain Medicine
Pain Management Perception
Pain Medication Pain
Pain Medications Pain management
Questionnaire Pain
Relative Risk

Semantics

Type Source Name
drug DRUGBANK Acetaminophen
drug DRUGBANK Ibuprofen
gene UNIPROT TNFSF13
gene UNIPROT ANP32B
disease MESH risk factors
disease MESH Satisfaction

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *